M&A Deal Summary |
|
|---|---|
| Date | 2022-07-26 |
| Target | La Vie Saine |
| Sector | Retail |
| Buyer(s) | Marcel & Fils |
| Sellers(s) | Andera Partners |
| Deal Type | Add-on Acquisition |
SEARCH BY
Marcel & Fils is a retail chain specializing in organic products. The Company offers a large range, mostly of food products (fruit and vegetables, fresh produce, bread, groceries, patisseries and savouries, gluten-free products, etc.) while also providing complimentary organic products such as cosmetics, nutritional supplements, home care items, and baby products, etc. Marcel & Fils was founded in 2008 and is based in Venelles, France.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Retail M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| Country: France M&A | 1 of 1 |
| Year: 2022 M&A | 1 of 1 |
| Category | Private Equity Firm |
|---|---|
| Founded | 2001 |
| PE ASSETS | 3.7B EUR |
| Size | Large |
| Type | Sector Agnostic |
Andera Partners is a private investment firm focused on several strategies. The Firm invests in life science opportunities through its BioDiscovery group. The Firm invests in Western European small to mid-sized companies (€30 to €300 million of revenue) through its Winch Capital group. Andera invests in small to mid-sized French companies (€10 to €100 million of revenue) through its Cabestan Capital team. Andera invests in €5 to €45 million of mezzanine capital to support small to mid-sized French companies. Andera Partners was established in 2001 and is headquartered in Paris.
| DEAL STATS | # |
|---|---|
| Overall | 31 of 52 |
| Sector: Retail M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 10 of 20 |
| Country: France M&A | 24 of 40 |
| Year: 2022 M&A | 3 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-06-08 |
Mineralys
Radnor, Pennsylvania, United States Mineralys is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. Its initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that the company is initially developing for the treatment of patients with uncontrolled hypertension. Mineralys was founded in 2019 and is based in Radnor, Pennsylvania. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-09-30 |
Vivoryon Therapeutics
Halle, Germany Vivoryon Therapeutics is a biopharmaceutical company focused on the development and commercialisation of new therapeutic products for the treatment of alzheimer’s disease (“AD”). Vivoryon Therapeutics was founded in 1997 and is based in Halle, Germany. |
Sell | - |
